Leveraging Behavioral Science to Improve Medicine Optimization Conversations With Older Adults
1 other identifier
interventional
2,420
1 country
1
Brief Summary
Our online, survey-based experiment will include 2,400 adults who are 65-years and older (n=1,200 each from United States and Australia). Each participant will be asked to give their opinions on a hypothetical patient scenario that has been developed by our diverse team in partnership with our stakeholder organizations.This work is expected to significantly contribute to our understanding of how older adults make decisions about deprescribing medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 19, 2024
CompletedFirst Posted
Study publicly available on registry
November 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2025
CompletedSeptember 26, 2025
November 1, 2024
3 months
November 19, 2024
September 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Preference regarding starting medication
Response to statement, "Based on what you have read so far, what would you prefer to do with this diabetes medicine?" on a 6-point Likert scale with scale anchors 1=Strongly prefer not to start medicine and 6=Strongly prefer to start medicine
1 year
Stopping medication
Response to statement, "Based on what you have read so far, what would you prefer to do with this diabetes medicine?" on a 6-point Likert scale with scale anchors 1=Strongly prefer not to continue and 6=Strongly prefer to stop
1 year
Study Arms (4)
Start medication - Lower chance of future health problems
EXPERIMENTALParticipants read a hypothetical scenario where a doctor recommends starting a new medication to lower their chances of experiencing significant health problems.
Start medication - Higher risk without medication
EXPERIMENTALParticipants read a hypothetical scenario where a doctor recommends starting a new medication because they could experience a higher risk of serious health problems without it
Stop medication - Lack of benefit
EXPERIMENTALParticipants read a hypothetical scenario where a doctor suggests stopping the medication due to a lack of benefit.
Stop medication - Potential for harm
EXPERIMENTALParticipants read a hypothetical scenario where a doctor suggests stopping the medication due to the potential for harm.
Interventions
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life.
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life but will periodically re-evaluate the benefits and risks of the medication.
Eligibility Criteria
You may qualify if:
- years and older and resides in Australia or the United States
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- University of Sydneycollaborator
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor of Clinical Pharmacy and Associate Chair, Clinical Pharmacy, College of Pharmacy
Study Record Dates
First Submitted
November 19, 2024
First Posted
November 21, 2024
Study Start
November 1, 2024
Primary Completion
January 30, 2025
Study Completion
January 30, 2025
Last Updated
September 26, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share